|Slideshows|February 16, 2017

Evaluating Smartphone Health Apps: 5 Key Steps

Finding a smartphone health app can be a challenge for both patients and physicians. A new evaluation model can help guide informed decision-making.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

The Positive Impact of Prescription Digital Therapeutics: Insights From Patricia Ares-Romero, MD

ByPatricia Ares-Romero, MD, FASAM

November 21st 2025

Prescription Digital Therapeutics: Transforming Health Care Delivery

ByLeah Kuntz

November 21st 2025

Using AI to Write Psychiatric Progress Notes

ByDinah Miller, MD

November 18th 2025

On Mentoring

ByJohn J. Miller, MD

October 9th 2025

Preliminary Report on Dangers of AI Chatbots

ByAllen Frances, MD,Luciana Ramos

October 7th 2025

Latest CME

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Evaluating Smartphone Health Apps: 5 Key Steps

Newsletter

Related Content

The Positive Impact of Prescription Digital Therapeutics: Insights From Patricia Ares-Romero, MD

Prescription Digital Therapeutics: Transforming Health Care Delivery

Using AI to Write Psychiatric Progress Notes

On Mentoring

Preliminary Report on Dangers of AI Chatbots

Latest CME

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Real Psychiatry 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

November in Review: Updates on the Psychiatric Treatment Pipeline

The Truth About Insomnia and Melatonin: Natural Does Not Always Mean Harmless

Looking Back: Key Insights from November 2025

New Drug Application Submitted for Centanafidine for Treatment of ADHD

Lithium Reduces Risk of Suicide and Recurrent Episodes of Bipolar and Major Depressive Disorders